Rituximab 500mg Injection for Oncology

Rituxirel RN 500mg Injection contains rituximab, a type of medicine known as an anti-CD20 monoclonal antibody. It is used in adults to treat various types of blood cancers like non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL). It also helps manage autoimmune diseases such as rheumatoid arthritis (RA), when used with methotrexate, as well as granulomatosis with polyangiitis and microscopic polyangiitis (inflammatory conditions affecting blood vessels). Additionally, it is prescribed for pemphigus vulgaris, a rare condition that causes painful skin blisters and sores in the mouth, throat, and other areas.

This injection works by targeting specific white blood cells called B-lymphocytes, which may grow abnormally in cancer or behave incorrectly in autoimmune conditions. Rituxirel RN 500mg is given under the supervision of a qualified healthcare professional. It’s not recommended if you are allergic to rituximab, have severe infections, or have a weakened immune system.

Before starting treatment, tell your doctor if you have heart or lung problems, or a history of hepatitis B infection, as the virus can reactivate during treatment. Pregnant and breastfeeding women should avoid this injection. Effective contraception is advised during treatment and for at least 12 months after the last dose.

Common side effects may include low red blood cells, infections, itchy skin, swelling, diarrhea, or changes in blood pressure. Serious side effects like infusion-related reactions, chest pain, or difficulty breathing should be reported to your doctor immediately.